Funding · Healthcare & Life Sciences
FutureCure Health raises ₹104 crore for vertigo care
By Startup Enthusiast ·
- Date
- Company
- FutureCure Health
- What it does
- Vertigo diagnosis and treatment
- Kind
- Funding
- Amount
- ₹104 crore ($11.5 million)
- Founded
- 2015
What they do
FutureCure Health is a healthcare technology company focused on super-speciality care
What happened
It raised ₹104 crore ($11.5 million) led by Carnelian Asset Management LLP
Why it matters
The company plans to expand vertigo diagnosis and treatment globally and into chronic conditions like migraine
The details
- FutureCure Health raised ₹104 crore ($11.5 million) in a funding round.
- The round was led by Carnelian Asset Management LLP with participation from other marquee investors.
- The company will use the funds to expand access to vertigo diagnosis and treatment in India and globally.
- It also plans to expand into chronic lifestyle conditions such as migraine and diabetes.
- FutureCure Health's subsidiary NeuroEquilibrium is the world's largest chain of vertigo and dizziness clinics.
- The company has over 300 clinics in India and 16 other countries.
- It has diagnosed and treated over 150,000 patients.
The bigger picture
- Vertigo and balance disorders affect nearly six crore people in India, many facing delayed or incorrect diagnoses.
- The company's approach identifies the root cause of vertigo for targeted treatment, not symptom suppression.
- Co-founder Anita Bhandari is a globally recognised expert in vertigo and balance disorders.
About the business
- FutureCure Health is a healthcare technology company focused on super-speciality care.
- Its wholly owned subsidiary NeuroEquilibrium operates the world's largest chain of vertigo and dizziness clinics.
- The company integrates advanced diagnostic systems, cloud-based remote platforms, and deep-tech innovation.
- It works with hospitals, ENT clinics, and neurology centres.
- The company has over 300 clinics in India and 16 other countries.
- It has served over 150,000 patients.
- The technology enables precision neuro-otology care beyond urban centres.
The deal
- Type
- funding
Investors
- Carnelian Asset Management LLP (lead)
Founders
- Rajneesh Bhandari, co-founder
- Anita Bhandari, co-founder
About FutureCure Health
- Product
- Super-speciality vertigo clinics and neuro-otology diagnostic and rehabilitation platforms through NeuroEquilibrium
- Customers
- Patients suffering from dizziness, vertigo, and balance disorders, as well as partner clinics and hospitals
- How it makes money
- Clinical diagnostic and rehabilitation treatment fees
- What sets it apart
- Root-cause diagnostic technology isolating inner ear, brain, or balance pathway issues for targeted care
Other articles talking about it
Same day
- Proost Beer achieves EBITDA breakeven in FY25 with revenue up 174%6 January 2026 · Results
- SkinInspired raises ₹24 crore in Series A6 January 2026 · Funding · ₹24 crore
- SusMafia gets ₹2 crore CSR grant from Zerodha6 January 2026 · Funding · ₹2 crore
- Simple Energy plans $30-50M raise ahead of 2027 IPO6 January 2026 · Funding · $30-50M
- BellaVita turns profitable in FY256 January 2026 · Results
- Blue Tokai narrows net loss as revenue surges6 January 2026 · Results